Al-Thani Hassan, El-Menyar Ayman, Al-Sulaiti Maryam, El-Mabrok Jamela, Hajaji Khairi, Elgohary Hesham, Al-Malki Ahmed, Tabeb Abdelhakem
Department of Surgery, Hamad Medical Corporation, Doha, Qatar.
Clinical Research, Trauma Surgery Section, Hamad Medical Corporation, Doha, Qatar ; Clinical Medicine, Weill Cornell Medical College, Doha, Qatar ; Internal Medicine, Ahmed Maher teaching Hospital, Cairo, Egypt.
Oman Med J. 2014 Nov;29(6):419-24. doi: 10.5001/omj.2014.112.
Our study aimed to analyze the clinical presentation, management, and outcome of renal angiomyolipoma patients incidentally detected upon computed tomography (CT) examination.
Between 2004 and 2008, all patients who underwent abdominal CT examination for any reason at the radiology department at Hamad General Hospital, Qatar were retrospectively reviewed. The diagnosis of renal angiomyolipoma was based on abdominal CT evaluation. Angiomyolipoma patients were followed-up by CT evaluation as per standard care for three years to observe any change in size and outcome.
A total of 13,115 patients were screened, of which 56 (40 females and 16 males) had renal angiomyolipoma. The mean age of patients was 52±13 years with 46% Qatar nationals. The majority (95%) of cases had unilateral tumors (52% right-sided and 43% left-sided). Twenty-six cases showed increase in tumor size and the median increase was 0.5cm (0.1-3.6). Surgical intervention was required in four (7%) cases with tumor size ≥4cm. The overall mortality on follow-up was 7%. The cause of death included metastasis, renal failure, hepatic failure and mesenteric thromboembolism.
Renal angiomyolipoma is an uncommon benign tumor with an overall prevalence of 0.4% in Qatar. It has characteristic clinical features and its recognition is often challenging for proper clinical diagnosis and treatment in asymptomatic patients. Asymptomatic patients need regular radiological surveillance. In contrast, surgical interventions are mainly required in symptomatic patients with increased tumor size (≥4cm). Timely diagnosis and treatment is necessary to avoid complications such retroperitoneal hemorrhage and renal impairment.
我们的研究旨在分析计算机断层扫描(CT)检查时偶然发现的肾血管平滑肌脂肪瘤患者的临床表现、治疗及预后。
回顾2004年至2008年期间,在卡塔尔哈马德总医院放射科因任何原因接受腹部CT检查的所有患者。肾血管平滑肌脂肪瘤的诊断基于腹部CT评估。按照标准护理方案,对血管平滑肌脂肪瘤患者进行为期三年的CT随访,以观察肿瘤大小及预后的任何变化。
共筛查了13115例患者,其中56例(40例女性和16例男性)患有肾血管平滑肌脂肪瘤。患者的平均年龄为52±13岁,其中46%为卡塔尔国民。大多数(95%)病例为单侧肿瘤(52%为右侧,43%为左侧)。26例肿瘤大小增加,中位数增加0.5cm(0.1 - 3.6cm)。4例(7%)肿瘤大小≥4cm的患者需要手术干预。随访期间的总死亡率为7%。死亡原因包括转移、肾衰竭、肝衰竭和肠系膜血栓栓塞。
肾血管平滑肌脂肪瘤是一种罕见的良性肿瘤,在卡塔尔的总体患病率为0.4%。它具有特征性的临床特点,对于无症状患者的正确临床诊断和治疗,其识别往往具有挑战性。无症状患者需要定期进行影像学监测。相比之下,有症状且肿瘤大小增加(≥4cm)的患者主要需要手术干预。及时诊断和治疗对于避免诸如腹膜后出血和肾功能损害等并发症是必要的。